logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (iv) All hallucinogen outpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium00000000022
Bulgaria00000000011
Czech Republic00000000000
Denmark04000000404
Germany155712004018922111
Estonia:::::::::::
Ireland11300000516
Greece10100000213
Spain1237157000162769
France213411422007431105
Italy2071600000231639
Cyprus00000000000
Latvia34511000011617
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary14100000606
Malta:1:::::::1:
Netherlands022000004711
Austria04000000404
Poland4:1:::::::::
Portugal501000000101
Romania00000000000
Slovenia:::::::::::
Slovakia00000000000
Finland00000000000
Sweden03010000404
United Kingdom670289862313114349953552
Croatia2::::::::::
Turkey:::::::::::
Norway00000000000
Total11745014836151745788148935
 

Notes:

: Indicates no data are available

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-11 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

Page last updated: Friday, 26 April 2013